Exact FDA event identifier

Event 94930

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: July 03, 2024
Product types: Drug
Classifications: Class II
Statuses: Ongoing
Recalling firm wording: TAILSTORM HEALTH INC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2

D-0594-2024

Recall number: D-0594-2024
Initiated: July 03, 2024
Classification: Class II
Status: Ongoing
Recalling firm: TAILSTORM HEALTH INC
Quantity: 12,525 10 mL vials

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent Drug: reduced efficacy for epinephrine

Code information

Lot Number: 2311003, Expiration Date: 11/13/2024

Distribution pattern

Nationwide in the USA